The frequency and severity of placental findings in women with preeclampsia are gestational age dependent.

OBJECTIVE The purpose of this study was to evaluate placental lesions found in women with preeclampsia compared with normotensive control subjects and to determine whether the presence of these lesions are related to gestational age at delivery. STUDY DESIGN Placental disease of women with preeclampsia at 24 to 42 weeks of gestation was compared with the placental disease of normotensive gestational age-matched control subjects. The placental lesions that were studied specifically included decidual arteriolopathy, thrombi in the fetal circulation, central infarction, intervillous thrombi, and hypermaturity of villi. Data analysis involved the chi(2) test, the Student t test, and logistic regression; odds ratios and CIs were estimated. RESULTS Placentas from women with preeclampsia (n=158) and normotensive control subjects (n=156) were evaluated. Among women with preeclampsia, 67% had severe disease. Placental lesions were studied according to gestational age at delivery: <28, 28 to 32, 33 to 36, and >or=37 weeks of gestation. Of the placental lesions that were studied, decidual arteriolopathy (odds ratio, 23.8, 95% CI 10.0-57.0), hypermaturity of villi (odds ratio, 12.4; 95% CI 5.3-29.2), intervillous thrombi (odds ratio, 1.95;95% CI 1.0-3.7), central infarction (odds ratio, 5.9; 95% CI 3.1-11.1), and thrombi in the fetal circulation (odds ratio, 2.8; 95% CI 1.2-6.6) were found to have significantly higher rates in the preeclamptic group. In contrast, the rate of chorioamnionitis was significantly lower in the preeclamptic group (odds ratio, 0.2; 95% CI 0.1-0.4). The rates of abruptio placentae and meconium staining were not different between the two groups. Within the preeclamptic group, the rates of decidual arteriolopathy (P<.0001), central infarction (P=.0001), and hypermaturity of villi (P<.0001) were higher the earlier the gestational age at delivery. CONCLUSION Placentas in women with preeclampsia have increased amounts of disease. The rate is increased with lower gestational ages at the time of delivery for women with preeclampsia.

[1]  B. Sibai,et al.  Prevention of preeclampsia with low‐dose aspirin in healthy, nulliparous pregnant women , 1993, The New England journal of medicine.

[2]  J. Cutler,et al.  Trial of calcium to prevent preeclampsia. , 1997, The New England journal of medicine.

[3]  J. Pezzullo,et al.  Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. , 1995, American journal of obstetrics and gynecology.

[4]  Khong Ty.  Acute atherosis in pregnancies complicated by hypertension, small-for-gestational-age infants, and diabetes mellitus. , 1991 .

[5]  D. Grové,et al.  Aggressive or Expectant Management for Patients With Severe Preeclampsia Between 28–34 Weeks' Gestation: A Randomized Controlled Trial , 1990, Obstetrics and gynecology.

[6]  J. Pezzullo,et al.  Placental pathologic features of preterm preeclampsia. , 1995, American journal of obstetrics and gynecology.

[7]  Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 1993 .

[8]  B. Nuwayhid,et al.  Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery? , 2000, American journal of obstetrics and gynecology.

[9]  Joshua R. Smith,et al.  Expectant management of early onset, severe pre‐eclampsia: perinatal outcome , 2000, BJOG : an international journal of obstetrics and gynaecology.

[10]  J. Kingdom,et al.  Oxygen and placental villous development: origins of fetal hypoxia. , 1997, Placenta.

[11]  François Teasdale,et al.  Histomorphometry of the human placenta in maternal preeclampsia. , 1985, American journal of obstetrics and gynecology.

[12]  K. Benirschke,et al.  Pathology of the Human Placenta , 1992, Springer New York.

[13]  B. Sibai,et al.  Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. , 1996, American journal of obstetrics and gynecology.

[14]  B. Sibai,et al.  Neonatal outcome after preterm delivery for preeclampsia. Discussion , 1995 .

[15]  R. Nijhawan,et al.  Abruptio placentae and chorioamnionitis ‐ microbiological and histologic correlation , 1999, Acta obstetricia et gynecologica Scandinavica.

[16]  B. Sibai,et al.  Neonatal outcome after preterm delivery for preeclampsia. , 1996, American journal of obstetrics and gynecology.

[17]  J. Pezzullo,et al.  Clinical correlations of patterns of placental pathology in preterm pre-eclampsia. , 1998, Placenta.

[18]  B. Sibai,et al.  Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. , 1994, American journal of obstetrics and gynecology.

[19]  D. Gersell.  ASCP Survey on Placental Examination , 1998 .

[20]  C. Langston,et al.  Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. , 1997, Archives of pathology & laboratory medicine.